GEMFIBROZIL

Post-LOE

gemfibrozil

ANDAORALTABLET
Approved
Sep 2010
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
11

Mechanism of Action

Peroxisome Proliferator-activated Receptor alpha Agonists

Pharmacologic Class:

Peroxisome Proliferator Receptor alpha Agonist

Clinical Trials (5)

NCT05959447Phase 1Completed

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

Started Jul 2023
45 enrolled
CoughHealthy
NCT05932303Phase 1Completed

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Started Jul 2023
47 enrolled
Healthy Participants
NCT04956627Phase 1Completed

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Started Jul 2021
15 enrolled
Healthy Participants
NCT06064539Phase 1Completed

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Started May 2020
30 enrolled
Multiple Sclerosis
NCT01836198Phase 1Completed

The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream

Started May 2013
30 enrolled
Healthy Volunteers